Semaglutide Injections Program

✓ Standard Formula. A compounded semaglutide treatment program for weight management.

If you are located in one of the states listed above, contact us to discuss other available treatment options.

Invyncible offers access to semaglutide through telemedicine. This version contains semaglutide only, without additional ingredients. Programs are organized into clear stages that reflect common treatment pathways.

We do not compound or dispense medications. Prescriptions are provided only after a licensed provider consultation and are filled by independent compounding pharmacies.

Program Options

Our semaglutide programs are structured to align with typical dosing schedules. Each program reflects a vial size and an approximate duration based on a weekly injection cycle.

Example: How Dosing Works

• Program 1 (starter): .5 mg weekly / 2.5 mg vial → ~5 weeks
• Program 2: ~1.0 mg weekly / 5 mg vial → ~5 weeks
• Program 3: ~2.0 mg weekly / 10 mg vial → ~4 weeks

⚠️ Examples only. Your provider determines the exact dosing schedule and vial size that are right for you.

How This Treatment Works

Semaglutide is a GLP-1 receptor agonist that helps regulate appetite and slow digestion. These effects can support reduced calorie intake and gradual weight management. Programs are structured for clarity, but providers personalize dosing to each patient.

Your Care Journey

• Submit Your Intake – Share your health history and goals through our secure online platform.
• Provider Consultation – A licensed provider reviews your information, answers questions, and confirms whether semaglutide is appropriate.
• Prescription Approval – If approved, the prescription is coordinated with a licensed compounding pharmacy.
• Structured Treatment Plan – Your provider determines the appropriate vial size and dosing pathway.
• Continued Care – Providers remain available throughout treatment for follow-up and support.

Side Effects

Common: nausea, vomiting, diarrhea, constipation, stomach pain, reflux, injection site reactions.
Less common but serious: pancreatitis, gallbladder disease, thyroid issues.

⚠️ This is not complete. Review full pharmacy documentation and consult your provider.

What We Do / Don’t Do

We Do:

• Provide telemedicine consultations
• Offer structured programs
• Coordinate with licensed pharmacies

We Don’t:

• Compound or dispense medications
• Sell medications directly

Important

• Compounded versions of semaglutide are not FDA-approved. Neither the FDA nor any other regulatory agency has reviewed these products for safety, quality, or effectiveness.
• Invyncible is a telemedicine provider network, not a pharmacy. Prescriptions are filled by licensed pharmacies.
• Important safety statement: This program is not intended to diagnose, treat, cure, or prevent any disease. Consult a licensed provider if pregnant, breastfeeding, or managing chronic conditions.

Questions?

If you have questions about programs, vial size, or treatment, our team is here.

Email | Call | Live Chat